Alcohol Use Disorders — Randomized Trial of Intensive Motivational Interviewing (IMI) to Improve Drinking Outcomes Among Women
Citation(s)
Burke BL, Arkowitz H, Menchola M The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003 Oct;71(5):843-61.
Downey L, Rosengren DB, Donovan DM Sources of motivation for abstinence: a replication analysis of the reasons for quitting questionnaire. Addict Behav. 2001 Jan-Feb;26(1):79-89.
Dunn C, Deroo L, Rivara FP The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction. 2001 Dec;96(12):1725-42. Review.
Miller WR, Yahne CE, Tonigan JS Motivational interviewing in drug abuse services: a randomized trial. J Consult Clin Psychol. 2003 Aug;71(4):754-63.
Miller WR What really drives change? Addiction. 1993 Nov;88(11):1479-80.
Mullins SM, Suarez M, Ondersma SJ, Page MC The impact of motivational interviewing on substance abuse treatment retention: a randomized control trial of women involved with child welfare. J Subst Abuse Treat. 2004 Jul;27(1):51-8.
Schneider RJ, Casey J, Kohn R Motivational versus confrontational interviewing: a comparison of substance abuse assessment practices at employee assistance programs. J Behav Health Serv Res. 2000 Feb;27(1):60-74.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
